Email your comments

As readers are no doubt aware, venous leg ulcers exert a huge morbidity on patients affected with chronic venous disease and can cause deterioration in patient’s quality of life. Four-layer bandaging is the gold standard for treatment of acute venous ulcers. If patients don’t respond to compression in the first 12 weeks of treatment it is of limited benefit thereafter. Treatments of chronic venous ulceration are at the forefront of wound healing research and development.

There have been many developments over the years to improve healing. We at Intercytex share your enthusiasm for improving on existing wound care for this patient group. Intercytex is a UK based, cellular therapy company and we are developing a unique wound healing application specifically to treat persistent venous leg ulcers. In previous studies Expert Wound Care Hospital Clinical Teams discovered that by delivering young cells to their patients, contained in the Intercytex gel normal, natural healing of the skin could be restored. The cells in the gel produce growth factors that in turn stimulate wound healing. 80% of ulcers treated showed significant improvement in the previous trial.

Intercytex is now running an international clinical trial for this product, which it has called ICX-PRO, at leading centres in the United Kingdom, Canada and USA. The trial is designed to treat 20% of patients who have not responded to current clinical treatment. 216 patients will be enrolled into the study that is designed to prove this new treatment works.

In the UK, Intercytex has started the next phase of the trial in Wirral, Manchester, Dudley, Birmingham, Bradford and Leeds. The sites are currently looking for patients with leg ulcers which are currently being treated with compression bandaging and have persisted for more than 3 months.

If you live in one of these regions and would be interested in participating in this trial, please contact our information line on 0800 032 9945.

Alternatively if you have a large population of patients who would benefit from participation in this trial, you run a dedicated leg ulcer clinic, have clinical trial experience and are interested in becoming a site for this trial then please contact Intercytex clinical team direct on 0161 904 4564.